Centre Hospitalier Universitaire de Toulouse
Our research team belongs to two highly connected institutions: the University Hospital of Toulouse (CHUT) and the Center for Physiopathology Toulouse-Purpan (CPTP).
Since 1958, the CHUT is an important collaborator for clinical trials but also for the development of challenging projects going from pre-clinic to the clinic. The CHUT is composed of 15 clinical departments, among them the Neurosciences department. The CHUT strongly interacts with biopharmaceutical companies, as shown by increasing numbers of protocols and clinical trials conducted. In clinical research field, the CHUT, actively contributes to medical and pharmaceutical sciences progress in collaboration with other institutions such as Universities, INSERM, CNRS.
Our research team is also part of the Center for Physiopathology Toulouse-Purpan (CPTP). Established in 2002, the CPTP is a leading research institute providing a productive scientific environment that is structured along three main themes: Immunology, inflammation and infectious diseases.The CPTP is affiliated with INSERM, CNRS and the University of Toulouse III. It is composed of 11 research teams with international reputation, 4 cutting-edge core facilities and an efficient support team (197 total members). Our research spans from basic research such as the development of the immune system and its functions to translational research. We investigate host-pathogen interactions and the onset of immune responses occurring in the context of viral infections (HIV, Zika virus, Hepatitis E, Influenza virus, cytomegalovirus, Borna virus) or parasitic infections (toxoplasma, malaria). We decipher the physiopathological mechanisms involved in autoimmune diseases (multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes) or allergies (asthma, atopic dermatitis). We also study anti-tumor responses and immune senescence. We conduct clinical studies on asthma, multiple sclerosis, HIV or neurodegenerative diseases. We are also engaged in optimizing vaccine strategies and developing novel immunotherapies.